Company Overview and News

0
Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down

2018-08-09 zacks
Perrigo Company plc (PRGO - Free Report) reported second-quarter 2018 adjusted earnings of $1.22 per share, which beat the Zacks Consensus Estimate of $1.21. Earnings growth was flat year over year.
SGEN VRTX PRGO UCTI OTCB UCTT

0
Green Thumb Industries Is Growing Under The Cannabis Radar

2018-07-19 seekingalpha
The stock price is at a nice entry level and the company isn't as overvalued as other peers.
OTCM BYSWF OTCB

4
John Lanchester · After the Fall: Ten Years after the Crash · LRB 5 July 2018

2018-06-29 lrb.co.uk
John Lanchester said he wasn’t going to watch any of the World Cup but as it happens he’s watching all of it.
WIMHF DB DTK WIMHY WMH OTCB

36
Procter & Gamble: A $79 Discounted Cash Flow Valuation

2018-06-25 seekingalpha
Procter & Gamble reported mixed Q3 earnings with organic revenue growth up just 1% below market expectations.
V MRK GOOGL GOOG MS OTCB

21
Treasure Hunting In The OTC Market

2018-06-22 seekingalpha
The market is efficient - it is harder and harder to find wonderful businesses at fair prices on major exchanges.
HRGLY SSNLF RTMVF RTMVY GOOG FUPEY FUPBY HL FUPEF HRGLF GOOGL LNSTY OTCB

6
Aphria Inc: Legalized Marijuana, Stock Dilution

2018-06-19 seekingalpha
The company has spent a lot of money becoming what will arguably be Canada's largest producer of medical and recreational marijuana.
APH APHQF OTCB

0
Future full of stars: WA touted as prime location for space agency hub

2018-05-22 smh.com.au
As the federal government sets aside money to look to the skies in the wake of the announcement of a national space agency, the case is already being put forward for WA to play a starring role in the organisation.
OTCB

1
Creso Pharma set to launch hemp-based nutraceutical in the Benelux region

2018-05-21 proactiveinvestors.com.au - 1
Creso Pharma Ltd (ASX:CPH) has signed a deal to commercialise its CBD (cannabidiol) hemp-based nutraceutical product cannaQIX® in the Benelux region (Belgium, the Netherlands, and Luxembourg).
OTCB

27
10 Sports Betting Stocks to Sink Your Teeth Into

2018-05-15 investorplace
It’s official … almost. After years of lobbying and pleading, the gambling industry finally got the nod of approval for the United States’ highest level of justice. The Supreme Court decided on Monday that the federal ban on sports betting that’s been in place for more than a couple of decades is an unconstitutional measure.
MGM WIMHF SGMS WYNN CHDN IGT WMH WIMHY MSG CZR PENN TSG OTCB

56
OTC crypto market flourishes, powered by Skype - Channel NewsAsia

2018-04-02 channelnewsasia - 1
Trading firms are negotiating buying, selling and lending digital currencies like bitcoin and ether over Skype, catering to big investors looking to avoid rocking already volatile online exchanges.
JBK GSC TFG GSJ GS GLSSP GJS OTCB

55
OTC crypto market flourishes, powered by Skype

2018-04-02 reuters
NEW YORK/LONDON (Reuters) - Trading firms are negotiating buying, selling and lending digital currencies like bitcoin and ether over Skype, catering to big investors looking to avoid rocking already volatile online exchanges.
JBK GSC TFG GSJ GS GLSSP GJS OTCB

0
Seatools exhibits quality with appearance models from 3D Systems On Demand Manufacturing

2018-03-26 australianmining.com.au
Australian 3D printing company 3D Systems has helped Netherlands-based company Seatools to show off its custom designs at the Offshore Technology Conference (OTC) in Houston, Texas.
OTCB

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...